ArticleAdvances in therapy2023

Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor.

Moshe C Ornstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.